Surgalign expands digital health capabilities

DEERFIELD — Surgalign Holdings Inc., a global medical technology company, Wednesday said it acquired an equity interest in Inteneural Networks Inc. in Chicago.

The deal includes use of Inteneural Networks' proprietary artificial intelligence (AI) technology for autonomously segmenting and identifying neural structures in medical images and helping identify possible pathological states.

Financial terms of the transaction were not disclosed.

Surgalign will also have the ability to acquire the remainder of Inteneural Networks' outstanding equity interests upon the achievement of certain regulatory, developmental and revenue-based commercial milestones. In June, the companies entered into a strategic collaboration agreement during which time Surgalign evaluated Inteneural Networks' technology for future integration within Surgalign's digital platform.

“This combination brings another foundational piece to our development efforts and accelerates our work to bring intercranial functionality to the HOLO technology platform,” said Terry Rich, Surgalign's president and chief executive officer. “This marks our first of many expansions outside of spine surgery and the operating room.”